baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AVEO Pharmaceuticals/ US0535883070 /

19/01/2023 22:00:01	Chg. -	Volume	Bid22:01:51	Ask22:01:51	High	Low
15.0000USD	-	247,877 Turnover: 3.34 mill.	14.9900Bid Size: 4,100	15.0000Ask Size: 7,600	15.0000	14.9900

GlobeNewswire 28/03 CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientif...

GlobeNewswire 25/03 AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Co...

GlobeNewswire 06/02 AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advan...

GlobeNewswire 16/01 AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in ...

GlobeNewswire 07/03/2022 AVEO Oncology to Announce Full Year 2021 Financial Results and Host Conference Call and Webcast on M...

GlobeNewswire 14/02/2022 AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivo...

GlobeNewswire 03/02/2022 AVEO Oncology Announces Participation at the 11th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire 20/01/2022 AVEO Oncology Presents Three Posters for Tivozanib/Immunotherapy Combinations at the 2022 ASCO GI Ca...

GlobeNewswire 04/01/2022 AVEO Oncology Highlights Recent Progress and 2022 Outlook

GlobeNewswire 22/12/2021 AVEO Oncology Announces Participation at the H.C. Wainwright Virtual BioConnect 2022 Conference

GlobeNewswire 20/12/2021 Finch Therapeutics Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer

GlobeNewswire 02/11/2020 Ziopharm Files Definitive Consent Revocation Statement and Sends Letter to Shareholders

GlobeNewswire 12/12/2019 Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors

GlobeNewswire 05/11/2019 CORRECTING and REPLACING -- XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and F...

GlobeNewswire 05/11/2019 XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results

GlobeNewswire 28/08/2019 Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer

GlobeNewswire 28/08/2019 Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer

GlobeNewswire 30/04/2019 Global Chronic Kidney Disease Markets and Technologies Through 2023

GlobeNewswire 26/04/2019 APRIL 26 DEADLINE: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed ...

GlobeNewswire 25/04/2019 CLASS ACTION UPDATE for CORT, AVEO, NIO and CRBP: Levi & Korsinsky, LLP Reminds Investors of Class A...

GlobeNewswire 25/04/2019 FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pha...

GlobeNewswire 24/04/2019 AVEO FRIDAY DEADLINE ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors of Important...

GlobeNewswire 23/04/2019 Class Action Alert CAG, DPLO & AVEO Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 19/04/2019 SHAREHOLDER ALERT: CORT AVEO MBT ARA: The Law Offices of Vincent Wong Reminds Investors of Important...

GlobeNewswire 18/04/2019 APR 26 DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pha...

AVEO Pharmaceuticals/ US0535883070 /

If you wish to receive reply to your feedback, please provide your email address.